Mesenchymal Stem Cell-derived Pleiotropic Factors (Chinese PLA General Hospital)

N/A

Report date: 2025/03/26 20:01:25

Base Information

Drug NameMesenchymal Stem Cell-derived Pleiotropic Factors (Chinese PLA General Hospital)
Drug Alias NameThe pleiotropic factor derived from mesenchymal stem cells
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsSurgical Wound
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesPla General Hospital
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPla General Hospital
Active IndicationsN/A
Inactive IndicationsSurgical Wound

Other Information

ATC CodeN/A
Related LinksN/A